Legal

Mutation

Also found in: Dictionary, Medical, Acronyms, Encyclopedia.
(redirected from Factor V Leiden mutation)

MUTATION, French law. This term is synonymous with change, and is particularly applied to designate the change which takes place in the property of a thing in its transmission from one person to another; permutation therefore happens when, the owner of the thing sells, exchanges or gives it. It is nearly synonymous with transfer. (q.v.) Merl. Repert. h.t.

A Law Dictionary, Adapted to the Constitution and Laws of the United States. By John Bouvier. Published 1856.
Mentioned in
References in periodicals archive
Activated protein C resistance and factor V Leiden mutation can be associated with first as well as secondtrimester recurrent pregnancy loss.
The association of factor V leiden mutation with recurrent pregnancy loss
Individuals who are heterozygous for the Factor V Leiden mutation carry a risk of venous thrombosis five to seven times higher than that of the general population; homozygous subjects have a risk 80 times higher.
A 52-year-old man with ecchymotic leg ulcers
[36] determined the prevalence of the factor V Leiden mutation in 73 patients with postthrombotic and nonpostthrombotic venous ulcers.
Association between thrombophilia and the post-thrombotic syndrome
(22.) Haslam N, Standen GR, Probert CS: An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease.
Inflammatory bowel disease and thrombosis / Inflamatuvar Bagirsak Hastaligi ve Tromboz
The factor V Leiden mutation is the most frequent cause of familial thrombosis and vWD is the most common inherited bleeding disorder.
A case of a combined commonly inherited bleeding and clotting disorder
Factor V Leiden mutation is present in the 4-6% of the general population and is the most common inherited cause of the syndrome accounting for the 40-50% of cases (1).
Combined heterozygote factor V Leiden mutation and anticardiolipin antibody positivity in a young patient with spontaneous deep vein thrombosis/Kombine heterozigot faktor V Leiden mutasyonu ve antikardiyolipin antikor pozitifligi olan genc bir hastada derin ven trombozu
(16) Since lupus anti coagulant may be a potential interferent in the modified assay, patients with lupus anticoagulant should be evaluated for the factor V Leiden mutation by genetic testing.
Factor V Leiden: an overview
The factor V Leiden mutation is the most common genetic thrombophilia: the heterozygous form, found in 5%-8% of the normal population, increases the risk of VTE five-fold, whereas the rarer homozygous form confers an 18-fold risk increase.
Genetics, OCs up venous thromboembolism risk
American College of Medical Genetics consensus statement on factor V Leiden mutation testing.
From peapods to laboratory medicine: molecular diagnostics of inheritable diseases. (Clinical Issues)
Prothrombin 20210 G: a mutation and Factor V Leiden mutation in women with a history of severe preeclampsia and (H)ELLP syndrome.
Bases geneticas y moleculares de la preeclampsia
Objectives: To determine the frequency of Protein C Protein S (PC and PS) antithrombin deficiency (AT III) and Factor V Leiden mutation (FVL) as a cause of thrombophilia in the patients with venous thromboembolism (VTE) and cerebrovascular accident (CVA).
High prevalence of protein C protein S antithrombin deficiency and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.